The clinical efficacy of TGF-β pathway inhibition and relevance of TGF-β signaling to tumor progression demonstrates that the pathway carries the potential to mediate oncogenic as well as tumor suppressive effects. The gene discussed is TGFB1; the disease is neoplasm.